José Ignacio Echeveste-rekin lankidetzan egindako argitalpenak (9)

2019

  1. Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

    International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001

2015

  1. Functional expression of CD137 (4-1BB) on T helper follicular cells

    OncoImmunology, Vol. 4, Núm. 12

  2. Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)

    Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 169-176

  3. Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators

    European Journal of Cancer, Vol. 51, Núm. 14, pp. 1897-1903

2014

  1. Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients

    Clinica Chimica Acta, Vol. 429, pp. 168-174

2013

  1. In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes

    European Journal of Immunology, Vol. 43, Núm. 7, pp. 1933-1939

2011

  1. Assessment of epidermal growth factor receptor and krasmutation status in cytological stained smears of non-small celllung cancer patients: Correlation with clinical outcomes

    Oncologist, Vol. 16, Núm. 6, pp. 877-885

  2. Identification of circulating nonclassic human leukocyte antigen G (HLA-G) - Like molecules in exudates

    Clinical Chemistry, Vol. 57, Núm. 7, pp. 1013-1022

2010

  1. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression

    Clinical Cancer Research, Vol. 16, Núm. 16, pp. 4113-4125